幹細胞市場規模、シェア、成長分析、製品別、用途別、技術別、治療法別、最終用途別、地域別 - 産業予測、2024～2031年

幹細胞の世界市場規模は2022年に119億米ドルと評価され、2023年の133億米ドルから2031年には316億米ドルに成長し、予測期間（2024～2031年）のCAGRは11.4%で成長する見通しです。

世界の幹細胞市場は、世界の臨床試験の増加と革新的な治療法の採用に後押しされ、大幅な成長が見込まれています。COVID-19の大流行により、幹細胞治療への関心が高まり、免疫調節治療への応用が有望視され、現在進行中の研究が行われています。これらの治療法へのアクセスを強化するためのCellino Biotech社の8,000万米ドルの資金調達に代表される多額の投資は、商業的進歩の可能性を示しています。オーストラリアの革新的な幹細胞プロジェクトに対する590万米ドルの資金提供のような政府のイニシアチブは、市場拡大をさらに後押ししています。しかし、高コストや倫理的ジレンマなどの課題も依然として残っています。このようなハードルにもかかわらず、再生医療に対する需要の高まりと継続的な研究努力は、幹細胞セクターの成長と機会のための有望な展望を提示し、企業と患者の両方に利益をもたらします。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• エコシステムマッピング
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術評価
• 規制情勢
• 顧客と購買基準の分析
• パイプライン分析
• 疾病疫学
• 特許分析

幹細胞市場規模：製品別およびCAGR（2024～2031年）

• 市場概要
• 成体幹細胞（ASC）
  • 造血
  • 間葉系
  • ニューラル
  • 上皮/皮膚
  • その他
• ヒト胚性幹細胞（HESC）
• 人工多能性幹細胞（IPSC）
• 非常に小さな胚様幹細胞

幹細胞市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 再生医療
  • 神経学
  • 整形外科
  • 腫瘍学
  • 血液学
• 心血管疾患および心筋梗塞
  • 負傷
  • 糖尿病
  • 肝疾患
  • 失禁
  • その他
• 医薬品の発見と開発

幹細胞市場規模：技術別およびCAGR（2024～2031年）

• 市場概要
• 細胞獲得
  • 骨髄採取
  • 臍帯血
  • アフェレーシス
• 細胞生産
  • 治療用クローン
  • 体外受精
  • 細胞培養
  • 分離
• 凍結保存
• 増殖および継代培養

幹細胞市場規模：治療法およびCAGR（2024～2031年）

• 市場概要
• 自家移植
• 同種異系

幹細胞市場規模：最終用途別およびCAGR（2024～2031年）

• 市場概要
• 製薬・バイオテクノロジー企業
• 病院と細胞バンク
• 学術調査機関

幹細胞市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Thermo Fisher Scientific, Inc.
• STEMCELL Technologies Inc.
• Merck KGaA
• CellGenix GmbH
• PromoCell GmbH
• Takara Holdings, Inc.
• Lonza
• Cellular Engineering Technologies
• ATCC
• AcceGen
• Cell Applications, Inc.
• Bio-Techne
• Organogenesis
• FUJIFILM Cellular Dynamics
• Gamida Cell
• GE Healthcare
• Pluristem Therapeutics
• Cynata Therapeutics
• Smith+Nephew
• Medipost

結論と推奨事項

Global Stem Cell Market size was valued at USD 11.9 billion in 2022 and is poised to grow from USD 13.3 billion in 2023 to USD 31.6 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).

The global stem cell market is poised for substantial growth, propelled by an increase in clinical trials and the adoption of innovative therapies worldwide. The COVID-19 pandemic has heightened interest in stem cell treatments, with promising applications in immunomodulation therapies leading to ongoing studies. Significant investments, exemplified by Cellino Biotech's USD 80 million funding to enhance access to these therapies, underline the potential for commercial advancements. Government initiatives, such as Australia's USD 5.9 million funding for innovative stem cell projects, further support market expansion. However, challenges including high costs and ethical dilemmas persist. Despite these hurdles, the rising demand for regenerative medicine and ongoing research efforts present a promising landscape for growth and opportunities in the stem cell sector, benefitting both businesses and patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stem Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stem Cell Market Segmental Analysis

Global Stem Cell Market is segmented by Product, Application, Technology, Therapy, End-Use and Region. Based on Product, the market is segmented into Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells. Based on Application, the market is segmented into Regenerative Medicine, Cardiovascular and Myocardial Infraction, Drug Discovery and Development. Based on Technology, the market is segmented into Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture. Based on Therapy, the market is segmented into Autologous, Allogeneic. Based on End-Use, the market is segmented into Pharmaceutical and Biotechnology Companies, Hospitals & Cell Banks, Academic & Research Institutes. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stem Cell Market

One of the primary drivers of the global stem cell market is the escalating incidence of chronic diseases, including cancer, diabetes, and cardiovascular conditions. This rise in health issues is fueling a growing demand for stem cell therapies, which are being explored as effective treatment alternatives. For example, stem cell therapy for knee pain, particularly due to osteoarthritis, has emerged as a promising non-surgical solution. As more patients seek these innovative therapeutic options to combat chronic ailments, the stem cell market is anticipated to experience considerable expansion, highlighting the pivotal role of stem cell treatments in modern medicine.

Restraints in the Global Stem Cell Market

A significant challenge facing the global stem cell market is the elevated cost linked to stem cell therapies, such as transplants, injections, and various treatments. These high expenses act as a barrier to widespread adoption, especially in developing nations where financial resources may be limited. Consequently, numerous patients find themselves unable to afford these advanced treatments, which in turn hinders the overall growth potential of the market. The affordability issue underscores the need for more accessible solutions and pricing models to enhance patient access and foster broader utilization of stem cell therapies.

Market Trends of the Global Stem Cell Market

The global stem cell market is witnessing a significant trend towards personalized medicine, reshaping therapeutic approaches across various medical conditions. The customization of stem cell therapies to cater to individual patient profiles - including genetic makeup and medical histories - is becoming prevalent, particularly in treatments for knee ailments and other disorders. This evolution is propelled by groundbreaking advancements in stem cell research and technology, which are facilitating the creation of tailored treatments that maximize efficacy and improve patient outcomes. As healthcare shifts towards more individualized approaches, the demand for personalized stem cell therapies is expected to escalate, positioning this segment for substantial growth in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Stem Cell Market Size by Product & CAGR (2024-2031)

• Market Overview
• Adult Stem Cells (ASCs)
  • Hematopoietic
  • Mesenchymal
  • Neural
  • Epithelial/Skin
  • Others
• Human Embryonic Stem Cells (HESCs)
• Induced Pluripotent Stem Cells (IPSCs)
• Very Small Embryonic Like Stem Cells

Global Stem Cell Market Size by Application & CAGR (2024-2031)

• Market Overview
• Regenerative Medicine
  • Neurology
  • Orthopaedics
  • Oncology
  • Haematology
• Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery and Development

Global Stem Cell Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture

Global Stem Cell Market Size by Therapy & CAGR (2024-2031)

• Market Overview
• Autologous
• Allogeneic

Global Stem Cell Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Hospitals & Cell Banks
• Academic & Research Institutes

Global Stem Cell Market Size & CAGR (2024-2031)

• North America (Product, Application, Technology, Therapy, End-Use)
  • US
  • Canada
• Europe (Product, Application, Technology, Therapy, End-Use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, Technology, Therapy, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, Technology, Therapy, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Technology, Therapy, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellGenix GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellular Engineering Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Applications, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Cellular Dynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gamida Cell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pluristem Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynata Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medipost
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation